Maryland Tribune
SEE OTHER BRANDS

The most trusted news from Maryland

Maryland Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tribune.

Press releases published on July 24, 2025

August Homes Recognized as Leading Maryland Custom Home Builder for Luxury and Energy-Focused Design

August Homes Recognized as Leading Maryland Custom Home Builder for Luxury and Energy-Focused Design

August Homes Recognized as Leading Maryland Custom Home Builder for Luxury and Energy-Focused Design ANNAPOLIS, MD, UNITED STATES, July 24, 2025 /⁨EINPresswire.com⁩/ -- August Homes, a Maryland custom home builder, has been named one of the top custom …

Baltimore's Largest Single-Day Fundraiser for Black-Led Organizations Returns August 8

Baltimore's Largest Single-Day Fundraiser for Black-Led Organizations Returns August 8

24-Hour Campaign on August 8 Seeks 20,000 Donors During Black Philanthropy Month BALTIMORE, MD, UNITED STATES, July 24, 2025 /⁨EINPresswire.com⁩/ -- CLLCTIVGive returns August 8, 2025, as Baltimore's premier 24-hour crowdfunding campaign dedicated to …

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the …

EB5 Capital Celebrates the Closing of Atlanta Woodrow Apartments (JF41)

EB5 Capital Celebrates the Closing of Atlanta Woodrow Apartments (JF41)

WASHINGTON, July 24, 2025 (GLOBE NEWSWIRE) -- EB5 Capital is pleased to announce the closing of its $42.4 million investment in Woodfield Development’s Atlanta Woodrow Apartments (JF41) project. Located in Atlanta, Georgia, the high-unemployment Target …

Forterra and Higher Ground Announce Mission Driven Partnership

Forterra and Higher Ground Announce Mission Driven Partnership

Ketchum, Idaho, July 24, 2025 (GLOBE NEWSWIRE) -- Forterra, a leader in autonomous systems for defense, today announced a formal partnership with Higher Ground, the nationally recognized nonprofit dedicated to transforming the lives of veterans, first …

Tenable Unveils AI-Powered Breakthrough in Vulnerability Prioritization

Tenable Unveils AI-Powered Breakthrough in Vulnerability Prioritization

COLUMBIA, Md., July 24, 2025 (GLOBE NEWSWIRE) -- Tenable®, the exposure management company, today announced the next evolution of its industry-leading Tenable Vulnerability Priority Rating (VPR) to sharpen precision and focus on risks that pose the …

Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference

Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference

BETHESDA, Md., July 24, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next-generation of allosteric small molecule therapies, …

TeraWulf Schedules Second Quarter 2025 Earnings Call for Friday, August 8 at 8:00 a.m. ET

TeraWulf Schedules Second Quarter 2025 Earnings Call for Friday, August 8 at 8:00 a.m. ET

EASTON, Md., July 24, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, next-generation digital infrastructure powered by predominantly zero-carbon energy, today …

Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

Autolus Therapeutics to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

LONDON and GAITHERSBURG, Md., July 24, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions